Analyst Ratings for Outlook Therapeutics Inc. (OTLK)
OTLK Rating Summary
OTLK Price Target Summary
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$6.75 (+327.2%)
* Over Last 12-Mos
Rating Score: 5 / 10
Percentile Rank: 52%
Avg. $ Target:
$6.75 (+327.2%)
* Over Last 12-Mos
Rating Score: 5 / 10
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/18/2026 | BTIG | Julian Harrison | Downgrade | Neutral (Buy) |
N/A (N/A) |
0.23 (1.58) |
586.96% | Details |
| 8/29/2025 | H.C. Wainwright » Updated 1/5/2026 |
Douglas Tsao | Downgrade | Neutral (Buy) |
0.50 (1.00) |
1.09 (1.58) |
44.95% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


